DOC PREVIEW
UIC PCOL 425 - Herb-drug interactions

This preview shows page 1-2-3-4-5-6 out of 17 pages.

Save
View full document
View full document
Premium Document
Do you want full access? Go Premium and unlock all 17 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 17 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 17 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 17 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 17 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 17 pages.
Access to all documents
Download any document
Ad free experience
Premium Document
Do you want full access? Go Premium and unlock all 17 pages.
Access to all documents
Download any document
Ad free experience

Unformatted text preview:

1Herb-drug interactionsCharlotte Gyllenhaal, Ph.D.1,3Gail Mahady, Ph.D.2Departments of Medicinal Chemistry and Pharmacognosy,1Pharmacy Practice2Block Center for Integrative Cancer Treatment36-1870, [email protected]▶ Evidence for herb-drug interactions▶ Pharmacokinetic (PK) versus pharmacodynamic(PD) interactions▶ St. John’s wort▶ Warfarin▶ Miscellaneous▶ Herb-drug interactions and surgical/dentalprocedures▶ Use of computer databases for clinical questions2Evidence for herb-drug interactions▶ Case reports Underreported? 70% “don’t ask-don’t tell”▶ Lab studies Define mechanisms▶ Recent interest in CYP450 induction▶ Not necessarily borne out in trials▶ Human studies Trials using probe drugs May be too short or expensive May be done on healthy population (not always) Genetic polymorphisms Multiple drug/herb users, elderly patientsDe Smet, Br J Clin Pharm 2006; 63:258-67Drug Interaction Resolution▶ Require dosage adjustments▶ Temporary or complete elimination of oneor the other agent to avoid seriousconsequences▶ Close monitoring of the subject▶ Total change of drug therapy3PK vs PD▶ PK: absorption, distribution, metabolism, elimination CYP450, PgP Absorption from GI tract (laxatives)▶ PD: pharmacological function Anticoagulant drugs plus anticoagulant herbs Sedative herbs plus anesthesia▶ Negative Most▶ Positive or synergistic Possible PD or PK Decrease side effectsPrevalence: unknown but underinvestigation▶ Canadian seniors with osteoarthritis Survey, n = 191. Average 2.8 prescriptions, 1.9 self-care products▶ Potential interactions detected using standarddatabases 214 instances, 14% possible clinical significance 7 herbs/supplements, associated with 5 clinicallyinsignificant interactions 1 recommendation to stop medications (dilatiazem +atrorvastatin -> statin side effects intensified) Clinically significant interactions may be rare – but thuseasier to forget about and harder to monitor!Putnam, Can Fam Physician 2006; 52:340-454St. John’s wort (Hypericumperforatum)▶ Mild-moderate depression -> long-term treatment;multiple clinical trials, fewer AEs than conventionaldrugs▶ Case reports suggesting PK interactions (mostimportant of SWJ interactions)▶ Lab studies indicate PK interactions:▶ CYP450 3A4 mechanism▶ short-term inhibition▶ Long-term induction; of most importance clinically▶ Reduces various drugs to subtherapeutic levels▶ Hyperforin, an active constituent, is a ligand for the xenobioticpregnane X receptor -> CYP450 3A4St John’s wort▶ Other PK interactions▶ P-glycoprotein (PgP): involved in multidrugresistance, acts as a pump to remove drugsfrom cells SJW induces this orphan nuclear receptor Also regulates MDR-1 (multidrug resistancegene) and other drug transportersChavez, Life Sci 2006; 78:2146-575St. John’s wort: PK interactions▶ Human trial with irinotecan (cancer) Blood levels of active metabolite were reduced▶ Other drugs affected Cyclosporin, tacrolimus, indinavir, nevirapine, imatinib,alprazolam, midazolam, amitriptyline, digoxin, fexofenadine,methadone, omeprazole, theophylline, verapamil, etoposide. Human study with oral contraceptives indicating reduce OCexposure and breakthrough bleeding. Case of delayed emergence from general anesthesia observed. Multiple potential interactions with oncology drugs (but rare useby oncology patients?).▶ Other CYP450s May inhibit CYP1A2, does not inhibit CYP2D6Murphy Contraception 2005; 71:402-8St. John’s wort▶ PD interactions With other antidepressants▶ Serotonin syndrome SJW has both SSRI and MAO inhibitor activity Restlessness, nausea, vomiting, tachycardia,hallucinations etc. Case reports with buspirone, loperamil, nefazodone,paroxetine, sertraline, venlafaxine▶ Possible adrenergic crisis MAO inhibitor activity▶ Photosensitivity Active constituent hypericin is photosensitizing butgenerally not a problem with healthy persons.Potential interaction with other photosensitizing drugs6Clinical strategy▶ Avoid use with other medications unlesschecked out in an interaction database. Willhave similar interaction profile to otherCYP450 3A4 inducers. Major drug-drug interaction pathwayWarfarin-herb interactions▶ Numerous drug-drug interactions: macrolides,NSAIDs, COX2s, SSRIs, omeprazole, 5FU etc(variable quality of evidence).▶ Possible pathways: Vitamin K activity lowers INR Foods: leafy greens (healthy diet) “Green drinks” – clinical interactions with oncologypatients. Case reports with cranberry juice also. Multivitamins CoQ10: similar structure to vitamin K, but RCT foundno effect on INR. Case reports suggest monitoring.Rhode, Curr Opin Clin Nutr Metab 2007; 10:1-5Engelsen, Throm Hemost 2002; 87:1075-67Warfarin-herb interactions▶ PK decreased absorption from GI tract due to mucilage(comfrey, Iceland moss) or laxative herbs (senna,rhubarb etc) CYP450 2C9 inhibition/induction, which metabolizes theactive S-enantiomer of warfarin▶ PD herbs that decrease platelet aggregation Decreased thromboxane synthesis Herbs with coumarin content (though this is a relativelyweak anticoagulant)Warfarin and Chinese herbs▶ Dan-shen (Salvia miltiorrhiza) – animal studies, casereports▶ Dong quai (Angelica sinensis) – animal studies, casereports▶ Asian ginseng (Panax ginseng) – ginsenosides may inhibitplatelet aggregation (anticoagulant). 2 case reports oflowered or unsteady INR (procoagulant) RCT in healthy volunteers showed no effect of Asian ginseng onINR, platelet aggregation. Vitamin K in extracts? Monitor closely.▶ American ginseng (Panax quinquefolius) – RCT in healthyvolunteers indicated moderately reduced INR, warfarinlevels, AUC. Avoid with warfarin.Chavez, Life Sci 2006; 78:2146-57Jiang, Br J Clin Pharm 2004; 57:592-9Yuan, Ann Intern Med 2004; 141:23-78Warfarin and “G” herbs▶ Garlic (Allium sativum) – 2 case reports. Continuingingestion of high levels of garlic or garlic oil can decreaseplatelet aggregation▶ Ginger (Zingiber officinalis) – Inconclusive results in studiesin healthy volunteers but case reports exist.▶ Ginkgo (Ginkgo biloba) – Ginkgolide B decreases PAF,extract inhibits thromboxane and prostacyclin in diabetics.Preliminary human study indicates no effect on INR, but acase report suggests interaction▶ Green tea (Camellia sinensis) – Inhibits


View Full Document

UIC PCOL 425 - Herb-drug interactions

Documents in this Course
Exam 3

Exam 3

7 pages

Kozasa

Kozasa

14 pages

Load more
Download Herb-drug interactions
Our administrator received your request to download this document. We will send you the file to your email shortly.
Loading Unlocking...
Login

Join to view Herb-drug interactions and access 3M+ class-specific study document.

or
We will never post anything without your permission.
Don't have an account?
Sign Up

Join to view Herb-drug interactions 2 2 and access 3M+ class-specific study document.

or

By creating an account you agree to our Privacy Policy and Terms Of Use

Already a member?